Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
. The HEXAPIC project aims to develop a novel high-performance Particle-In-Cell (PIC) code for plasma physics simulations, leveraging the capabilities of exascale computing systems. By optimizing PIC algorithms
-
Micha, Research Engineer at CNRS/ESRF, This Post-doctoral position focuses on the development of interpretable artificial intelligence methods for detecting and analysing anomalies in synchrotron beamline
-
available to work on computational models of artificial evolution for aptamer design, expected to start between November 2025 and February 2026. Aptamers are often obtained through rounds of in vitro
-
to drive progress in translational medicine, improving diagnostics and healthcare solutions. For more information, please visit our page. You will be the scientific liaison for a team developing secure and
-
to preserve the internal charge and handle the output signal of the RE (buffering function, polarity and gain adjustment). More precisely, a new embedded analog system will be developed, tested and evaluated
-
a view to developing innovative treatments for hearing impairments. The Hearing Institute The Hearing Institute is an interdisciplinary fundamental and medical research center with the objective
-
within the Faculty. Along with the disciplinary approach a very ambitious interdisciplinary research culture has been developed. The faculty's research and teaching focuses on social, economic, political
-
of the auditory nerve [2] and brainstem to simulate neurograms and guide the development of diagnostic tools based on Auditory Brainstem Responses (ABRs). Despite normal audiograms, individuals with ANSD often
-
A post-doctoral position in human population genomics is opening in our lab to work on the POPGEN project. The POPGEN project is a pilot research project developed in the framework of the French
-
prognosis. Gene therapy holds a great promise for the development of cures for these devastating pathologies.The project is funded by The POLG foundation. We are conducting preclinical development of an AAV